GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Adcock Ingram Holdings Ltd (OTCPK:AIHLF) » Definitions » EV-to-EBITDA

Adcock Ingram Holdings (Adcock Ingram Holdings) EV-to-EBITDA : 6.70 (As of May. 05, 2024)


View and export this data going back to . Start your Free Trial

What is Adcock Ingram Holdings EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Adcock Ingram Holdings's enterprise value is $448.7 Mil. Adcock Ingram Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $67.0 Mil. Therefore, Adcock Ingram Holdings's EV-to-EBITDA for today is 6.70.

The historical rank and industry rank for Adcock Ingram Holdings's EV-to-EBITDA or its related term are showing as below:

AIHLF' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.42   Med: 9.21   Max: 14.39
Current: 6.65

During the past 13 years, the highest EV-to-EBITDA of Adcock Ingram Holdings was 14.39. The lowest was 5.42. And the median was 9.21.

AIHLF's EV-to-EBITDA is ranked better than
82.41% of 705 companies
in the Drug Manufacturers industry
Industry Median: 14.53 vs AIHLF: 6.65

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-05), Adcock Ingram Holdings's stock price is $2.45. Adcock Ingram Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.294. Therefore, Adcock Ingram Holdings's PE Ratio for today is 8.33.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Adcock Ingram Holdings EV-to-EBITDA Historical Data

The historical data trend for Adcock Ingram Holdings's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adcock Ingram Holdings EV-to-EBITDA Chart

Adcock Ingram Holdings Annual Data
Trend Sep13 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.51 8.29 6.44 5.99 6.04

Adcock Ingram Holdings Semi-Annual Data
Mar14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 5.99 - 6.04 -

Competitive Comparison of Adcock Ingram Holdings's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Adcock Ingram Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adcock Ingram Holdings's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Adcock Ingram Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Adcock Ingram Holdings's EV-to-EBITDA falls into.



Adcock Ingram Holdings EV-to-EBITDA Calculation

Adcock Ingram Holdings's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=448.709/66.999
=6.70

Adcock Ingram Holdings's current Enterprise Value is $448.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Adcock Ingram Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $67.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adcock Ingram Holdings  (OTCPK:AIHLF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Adcock Ingram Holdings's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2.45/0.294
=8.33

Adcock Ingram Holdings's share price for today is $2.45.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Adcock Ingram Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.294.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Adcock Ingram Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Adcock Ingram Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Adcock Ingram Holdings (Adcock Ingram Holdings) Business Description

Traded in Other Exchanges
Address
1 New Road, (c/o New Road & 7th Street), Midrand, Johannesburg, GT, ZAF, 1682
Adcock Ingram Holdings Ltd is a drug manufacturing company. The company manufactures, markets, and distributes a wide range of healthcare products. The company generates roughly two-thirds of its sales from the private sector, with the remaining from the public sector. Adcock operates in four broad areas: renal disease, medicine delivery, transfusion therapies, and blood and specialized pharmaceuticals. The company generates the vast majority of its revenue in southern Africa, followed by the rest of Africa and India.

Adcock Ingram Holdings (Adcock Ingram Holdings) Headlines

From GuruFocus